During the past decade, Hospital Marítimo de Torremolinos conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Marítimo de Torremolinos" are "Schizophrenia" (2 trials), "Autism" (1 trials) and "Bipolar Depression" (1 trials). Many other conditions were trialed in "Hospital Marítimo de Torremolinos" in a lesser frequency.

Most popular intervention types in "Hospital Marítimo de Torremolinos" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone 20, 40, 60, 80 mg, flexibly dosed" (1 trials), "Lurasidone 40 mg" (1 trials), "Lurasidone 80 mg" (1 trials) and "Placebo 40 or 80 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Marítimo de Torremolinos" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Marítimo de Torremolinos". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Marítimo de Torremolinos, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Marítimo de Torremolinos, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".